Analysis of the proportion of Chinese patent medicine retail market in 2015: which brands are the best sellers?

Source: in the middle of February 2016, the executive meeting of the State Council determined "two promotion and one relaxation" The policy is to promote the inheritance, protection and excavation of traditional Chinese medicine and national medicine, improve the ability of emergency treatment and disease prevention and treatment of traditional Chinese medicine, promote the integration of traditional Chinese and Western medicine, strengthen the prevention and treatment of major and difficult diseases, chronic diseases and other traditional Chinese medicine and new drug research and development, and relax the access of traditional Chinese medicine services The policy points out the development direction and service mode of traditional Chinese medicine, which is obviously beneficial to the development of traditional Chinese medicine in China Driven by favorable policies, the position of Chinese patent medicine in the retail market will be further improved 1 The market share of Chinese patent medicine accounts for 30% According to the monitoring of the meter intranet retail data, from the total sales share of various retail pharmacies in beishangguangsan city in 2015 (see Figure 1), chemical medicine, Chinese patent medicine and medicinal materials and other major health categories are in the third world, each of which accounts for about one third of the market share Chemical medicine is the first category, accounting for 38.05%; Chinese patent medicine accounts for 30.85%, which is the second category; large health category medicine, health care products, equipment, etc account for relatively small proportion On the one hand, the price of drugs in retail pharmacies is relatively cheap and the purchase of drugs is convenient In the hospital On the other hand, the new medical reform policy gradually leads patients to the hospital and the community to purchase drugs The outflow of hospital prescriptions is increasingly difficult, and the pressure of pharmacy management is significantly increased They gradually turn to expand the management of health care products, food, medical devices, medicines, cosmetics, milk powder and other major health categories As the second largest category of retail pharmacies, the market share of Chinese patent medicine in the retail market of beishangguangsan city in 2015 slightly increased by 0.06% year on year The advantages of traditional Chinese medicine in health preservation and prevention of diseases are obvious In the aspect of prevention and treatment of new diseases, its characteristics, advantages and curative effects are gradually recognized and recognized, as well as the establishment of Chinese medicine sitting hall and Chinese Medicine Health Preservation Hall in retail pharmacies, which are important factors affecting the increase of Chinese patent medicine share 2 The advantages of Chinese patent medicine for chronic diseases are obvious In 2015, the top five categories of Chinese patent medicine were common diseases, chronic diseases and tonic and health care drugs, which were cold, blood tonic, cough relieving, throat and cardio cerebral vascular The top five categories accounted for more than half of the market share Among them, the cold medicine accounts for the largest proportion, accounting for 14.32%; the next is nourishing blood, accounting for 13.34%; the other three categories are all less than 10% (see Figure 2) It is worth noting that the market share of throat and cardio cerebrovascular drugs related to chronic diseases increased by 0.56% and 0.78% respectively compared with that in 2014 (see Figure 3) 3 There are many traditional Chinese medicine products with low market concentration Cold is the first category in the sales of traditional Chinese medicine In 2015, there were more than 1000 varieties in the retail market of traditional Chinese medicine in beishangguangsan city From table 1, it can be seen that the market share of the top five brands is not large and the share of each brand is similar, and there is no real leading brand Beijing Tongrentang's Ganmao Qingre granules ranked first, accounting for 4.27% of the market share The total market share of the top five brands is 16.87%, with low market concentration 4 Dong'a-jiao takes the lead in blood tonifying products In 2015, beishangguang's total Chinese patent medicines for nourishing blood were mainly made of donkey hide gelatin and donkey hide gelatin products Dong'a-jiao, ranking first, has a leading market share of 62.42%, but its market share has declined to a certain extent Compound donkey hide gelatin paste ranked second, accounting for 13.34% The total market share of the top five brands is 92.11% (see Table 2) 5 The advantages of children 's cough medicine gradually showed up in the retail market of Chinese patent medicine in Kitakami Hiromi city in 2015 The market share of the product was 20.73% The market share of other brands is small and the gap is not large, and most of them have increased year-on-year Among the top five brands, children's drugs account for two, which are sunflower children's lung heat cough and asthma oral liquid and Lunan Houpu's children's Xiaoji cough and cough oral liquid, and their shares are on the rise (see Table 3) 6 Lanqin oral liquid is the leader in the market of throat medicine Laryngitis can be divided into acute pharyngitis and chronic pharyngitis Chronic pharyngitis is is mainly caused by repeated attacks caused by incomplete treatment of acute pharyngitis, which turns to chronic The main treatment drugs are antibiotics and proprietary Chinese medicine With the limited use of antibiotics, Chinese patent medicine plays an increasingly important role in the treatment of laryngitis The market share of Lanqin oral liquid produced by Yangzijiang Pharmaceutical Co., Ltd., the No 1 pharmaceutical company, soared to 14.25%, 5.69% higher than that in 2014, and 9% higher than the market share of golden throat tablets produced by Guangxi golden throat Co., Ltd., the No 2 pharmaceutical company, becoming the leading brand of throat drugs The market share of Qinghou Liyan granules produced by Guilong Pharmaceutical (Anhui), ranking third, has declined slightly compared with the same period last year, while the market share of other brands has increased In total, the top five brands account for one third of the market share, which is 32.98% The market concentration is not high (see Table 4) 7, the top five brands of cardiovascular and cerebrovascular diseases account for half of the market, cardiovascular and cerebrovascular diseases are the biggest killer of human beings They have the characteristics of "four high and one more", that is, high incidence rate, high disability rate, high mortality rate, high recurrence rate, and many complications 40% - 45% of the elderly over 60 years old suffer from one or more cardiovascular and cerebrovascular diseases At present, there are more than 270 million patients with cardiovascular and cerebrovascular diseases in China With the aging of the population, this group is growing Cardio cerebrovascular disease is a chronic disease, which needs to be taken for a long time Chemical drugs are resistant and have large side effects, so they are not suitable for taking for a long time On the contrary, Chinese patent medicine has little side effects and has the function of prevention and health care, which is suitable for long-term use At present, most of the drugs for cardiovascular and cerebrovascular diseases such as coronary heart disease, angina pectoris and stroke are Chinese patent medicine In 2015, the top three brands in the cardio cerebrovascular Chinese patent medicine market of beishangguangsan city were Fufang Danshen dropping pill, Shexiang Baoxin Pill and Angong Niuhuang Pill of Beijing Tongrentang The three brands had a stable position, with a share of more than 10% in the past three years Although the market share of quick acting Jiuxin Pill and Danshen tablet of Shanghai leiyunshang pharmaceutical industry is far away from the top three brands, they also play an important role in the retail market The top five brands together account for half of the market share, 47.31% (see Table 5) In February this year, the executive meeting of the State Council stressed the importance of traditional Chinese medicine in the prevention and treatment of chronic diseases Driven by favorable policies, the future of traditional Chinese medicine in the treatment of chronic diseases will play a greater role, and the market development prospect is worth looking forward to.